NLGIA
EW icon

Nippon Life Global Investors Americas’s Edwards Lifesciences EW Stock Holding History

Nippon Life Global Investors Americas’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67M Buy
+51,670
New +$4.33M 0.19% 62
2025
Q4 		– Sell
-51,840
Closed -$4.03M – 109
2025
Q3 		$4.03M Sell
51,840
-9,460
-15% -$739K 0.17% 66
2025
Q2 		$4.79M Sell
61,300
-8,150
-12% -$608K 0.21% 67
2025
Q1 		$5.03M Hold
69,450
– – 0.25% 67
2024
Q4 		$5.14M Buy
69,450
+4,570
+7% +$320K 0.24% 71
2024
Q3 		$4.28M Buy
+64,880
New +$4.71M 0.18% 74
2024
Q1 		– Sell
-21,190
Closed -$1.62M – 118
2023
Q4 		$1.62M Sell
21,190
-6,990
-25% -$486K 0.09% 95
2023
Q3 		$1.95M Sell
28,180
-34,020
-55% -$2.73M 0.12% 89
2023
Q2 		$5.87M Sell
62,200
-49,550
-44% -$4.31M 0.4% 57
2023
Q1 		$9.25M Buy
+111,750
New +$8.78M 0.59% 50
2022
Q4 		– Sell
-19,250
Closed -$1.59M – 132
2022
Q3 		$1.59M Sell
19,250
-37,680
-66% -$3.63M 0.11% 89
2022
Q2 		$5.41M Sell
56,930
-10,190
-15% -$1.05M 0.35% 83
2022
Q1 		$7.9M Buy
67,120
+6,320
+10% +$709K 0.42% 65
2021
Q4 		$7.88M Hold
60,800
– – 0.37% 74
2021
Q3 		$6.88M Sell
60,800
-4,580
-7% -$523K 0.36% 78
2021
Q2 		$6.77M Buy
65,380
+11,950
+22% +$1.13M 0.34% 83
2021
Q1 		$4.47M Hold
53,430
– – 0.24% 104
2020
Q4 		$4.88M Hold
53,430
– – 0.29% 88
2020
Q3 		$4.26M Hold
53,430
– – 0.28% 84
2020
Q2 		$3.69M Buy
+53,430
New +$3.8M 0.26% 92
2019
Q3 		– Sell
-47,070
Closed -$2.9M – 142
2019
Q2 		$2.9M Buy
47,070
+14,430
+44% +$873K 0.22% 106
2019
Q1 		$2.08M Sell
32,640
-216,840
-87% -$12.4M 0.17% 124
2018
Q4 		$12.7M Sell
249,480
-45,690
-15% -$2.31M 1.1% 30
2018
Q3 		$17.1M Buy
295,170
+30,540
+12% +$1.49M 1.31% 23
2018
Q2 		$12.8M Sell
264,630
-58,920
-18% -$2.75M 1.02% 34
2018
Q1 		$15M Buy
323,550
+14,310
+5% +$621K 1.24% 21
2017
Q4 		$11.6M Hold
309,240
– – 0.93% 37
2017
Q3 		$11.3M Sell
309,240
-30,510
-9% -$1.16M 0.96% 37
2017
Q2 		$13.4M Buy
339,750
+139,770
+70% +$5.1M 1.15% 29
2017
Q1 		$6.27M Buy
199,980
+28,950
+17% +$906K 0.56% 64
2016
Q4 		$5.34M Buy
+171,030
New +$5.54M 0.49% 76

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Nippon Life Global Investors Americas's EW Position: Q2 2026 in Review

Nippon Life Global Investors Americas opened a new position in Edwards Lifesciences (EW) in Q2 2026: 51,670 shares worth $4.67M. The stake represents 0.19% of the portfolio and ranks #62 among its holdings. This is a return to the name: Nippon Life Global Investors Americas previously reported a position in EW as recently as Q3 2025.

Nippon Life Global Investors Americas first reported a position in EW in Q4 2016 and has held it in 31 quarters since. The position peaked at $17.1M in Q3 2018. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Nippon Life Global Investors Americas held 51,670 shares of Edwards Lifesciences worth $4.67M as of Q2 2026.
  • Edwards Lifesciences was a new Nippon Life Global Investors Americas position in Q2 2026.
  • Edwards Lifesciences made up 0.19% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #62 holding.
  • Nippon Life Global Investors Americas first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 31 quarters since.
  • Nippon Life Global Investors Americas's Edwards Lifesciences position peaked at $17.1M in Q3 2018.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.